Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Morrisville Town Councilman Steve Rao Hosts Federation of Asian Biotech Associations Visit
Councilman Rao Welcomes Visit by India’s Largest Biotech and Pharmaceutical Organization in Morrisville - April 24, 2013 - Steve Rao
Metrics Inc. Adds Liquids, Creams, Gels to Manufacturing Capabilities
Company's scientists can develop new formulations or accept transfer of existing products - April 20, 2013 - Metrics, Inc.
Virtual Model of Novel Cancer Target Developed
Plebiotic and Pharmacellion Complete Research Project on an in silico Molecular Modelling and Molecular Dynamics Model of Na K ATPase. - April 12, 2013 - Ventac Partners
Greg Bonfiglio of Proteus Ventures to Speak at Stem Cell Summit (Apr 2013 Boston)
Gregory Bonfiglio from Proteus Venture Partners, will give a presentation on “Funding for Regenerative Medicine Technologies: Opportunities And Challenges” at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA). Greg Bonfiglio is a Managing Partner of Proteus Ventures and Chair... - April 11, 2013 - GTCbio
Upcoming Drug Safety Training Opportunities
Don’t Miss Two New Interactive Drug Safety Training Sessions by Dr. Michael J. Klepper, Global Pharmacovigilance Expert, Coming This Spring - April 09, 2013 - Drug Safety Navigator, LLC
Cytocentrics is Proud to Announce the Appointment of SciPro as Their New Distribution Partner
Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the appointment of SciPro Inc. as their distribution partner for the CytoPatch2 in North America. - March 28, 2013 - Cytocentrics
Michael M. Blumenthal, Ph.D. Recognized by Strathmore's Who's Who Worldwide Publication
Michael M. Blumenthal, Ph.D. of Metuchen, New Jersey has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of food science. About Michael M. Blumenthal, Ph.D. Dr. Blumenthal has over 31 years experience in the... - March 27, 2013 - Strathmore Worldwide
Hepatitis B Foundation to Host Annual Crystal Ball Fundraiser on May 3, 2013
National Nonprofit Dedicated to Curing Hepatitis B Honors Former Chief of Hepatitis Viruses Section, NIAID of the National Institutes of Health – Dr. Robert Purcell - March 27, 2013 - Hepatitis B Foundation
Bio-Synthesis Will Spotlight the New BNA Technology at AACR
Bridged Nucleic Acids exhibit increased stability in oligonucleotides. - March 22, 2013 - Bio-Synthesis Inc.
Sridaran Natesan of Sanofi to Present at the Stem Cell Summit 2013, Apr 29-30, 2013 in Boston, MA
Sridaran Natesan, Vice President of External Innovation at Sanofi will give a keynote presentation on “How To Make Pancreatic Beta Cells” at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA). Dr. Sridaran Natesan is a member of the leadership team of the Prospective Strategic... - March 21, 2013 - GTCbio
Tiina Palomaki of EMA to Present at Stem Cell Summit 2013, April 29-30, 2013 in Boston
Tiina Palomaki, Senior Researcher at The European Medicines Agency will present on “Regulatory Requirements for Stem Cell-based Medicinal Products in the EU” at GTC’s Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA). Stem cells hold the promise as a source of cells for... - March 21, 2013 - GTCbio
F2G Ltd Appoints Ian Nicholson as Chief Executive Officer
F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors. - March 20, 2013 - F2G Ltd
Mostafa Ronaghi SVP & CTO of Illumina to Keynote at GTC’s NGS meeting, Jun. 20-21, San Francisco
Mostafa Ronaghi, Senior Vice President and Chief Technology Officer of Illumina Will Give a Keynote Presentation on “The New Era of Medicine Enabled by Advancing NextGen Sequencing” at GTC’s 3rd Next Generation Sequencing Conference on June 20–21, 2013 in San Francisco, CA - March 16, 2013 - GTCbio
Dr. R. Wade McKenna to Speak on Stem Cell Therapy at T-POC & Newclip Technics 2013 Event
Dr. R. Wade McKenna, will share his expertise in stem cell therapy during the 2013 Dinner Event for The Progressive Orthopedic Company (T-POC) and Newclip Technics USA. The event will be held Friday, March 22 in Chicago, Illinois during the American Academy of Orthopaedic Surgeons 2013 Annual Meeting. - March 14, 2013 - Biologic Therapies
Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million
Economic Impact Study Reveals Huge Benefits for the Community of Bucks County and Pennsylvania - March 10, 2013 - Hepatitis B Foundation
Promoters for Improved Protein & Biopharmaceutics Production in Mammalian Cells
Synpromics Ltd, the synthetic promoter company, announces the award by the Technology Strategy Board, the UK’s innovation agency, of an over £240,000 grant under the TSB’s Synthetic Biology initiative to a consortium led by Synpromics and also including Genabler Ltd and the University of Edinburgh’s SynthSys Centre for Synthetic and Systems Biology. - March 09, 2013 - Synpromics Ltd
GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services
GenWay Biotech announces Ruben Flores-Saaib, PhD as Vice President of Custom and Catalog Services assuming responsibilities for the Company's custom services and catalog business operating activities. - March 06, 2013 - GenWay Biotech
The CytoPatch™2: Faster, Cheaper, and More Powerful
Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the release of the second generation GLP compliant CytoPatch™ instrument, the CytoPatch2. - March 06, 2013 - Cytocentrics
Mispro Biotech Services Announces Partnership with The Hamner Institutes for Health Sciences
Preclinical experts open vivarium facility in Research Triangle Park - February 28, 2013 - The Hamner Institutes for Health Sciences
Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on Oxford Gene Technology’s Patented Functional Protein Array
Sengenics today announced that it has signed an agreement with Oxford Gene Technology (OGT) to enable the launch of a global cancer biomarker discovery and clinical trial immuno-response monitoring service. The service will be based upon OGT’s proprietary full-length functional protein array... - February 25, 2013 - Sengenics
New Efficient Reagent for Stem Cell Transfection
DreamFect™ Stem transfection reagent from Oz Biosciences is specifically developed for transfection of Stem Cell. - February 23, 2013 - OZ Biosciences
GenScript Upgrade Free Bioinformatics Tools
GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers，as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.
World's First FDA Cleared ALK Automated Gene Scanner for Lung Cancer Therapy-Selection Available from ASI
Targeting the Right Treatment for the Right Patient in ALK Therapy Selection for Non-Small-Cell Lung Cancer - February 16, 2013 - Applied Spectral Imaging
Xeno Diagnostics, LLC Receives Award for Laboratory Excellence
Xeno Diagnostics, LLC Recognized for Quality Laboratory Services - February 15, 2013 - Xeno Diagnostics, LLC
iMPak Health Announces Agreement to License HealthSaaS Connected Outcomes Platform
iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak’s device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers. - February 13, 2013 - HealthSaaS, Inc
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits
AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group
GenScript Launches eBlot® Protein Transfer System
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.
Rosellini Scientific Chosen as a National Biomedical Vendor for Hospital Corporation of America and MedAssets
Rosellini Scientific, LLC, a biomedical engineering firm specializing in enhancing rehabilitation services for patients, has been approved as a national biomedical vendor for Hospital Corporation of America and MedAssets. - February 06, 2013 - Rosellini Scientific, LLC
Bioo Scientific Releases NEXTflex™ 16S V4 Amplicon-Seq Kit for Bacterial Metagenomics Studies
The NEXTflex™ 16S V4 Amplicon-Seq Kit has been developed to simplify bacterial metagenomics studies using Illumina® HiSeq and MiSeq platforms. This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available. Using specialized NEXTflex... - February 06, 2013 - Bioo Scientific
GenScript Launches New PolyExpress Package
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.
New Independent Validation Study of ProtoCOL 3 System Shows System's Rapid Performance is as Accurate as Manual Colony Counting
Synbiosis, a world-leading manufacturer of automated microbiological systems, is delighted to announce its ProtoCOL 3 rapid automated colony counter has been shown in an independent study to perform with the same level of accuracy as manual colony counting for enumerating 10 different types of microbial colonies on a range of agar plates. - February 02, 2013 - Synbiosis
Stem Cell Expert Dr. R. Wade McKenna to Speak at International Stem Cell Society Conference
Biologic Therapies (www.biologictherapies.com), a medical device company specializing in the design and manufacturing of proprietary medical components focused on autologous stem cell therapy and regenerative medicine, has announced its Chief Medical Director, Dr. R. Wade McKenna, will share his... - January 29, 2013 - Biologic Therapies
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
ProteinSignal - A New Brand of GenScript, Focused on Protein Research
ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.
Gary Novack of PharmaLogic to Speak at 5th Ocular Diseases Conference March 2013
Gary Novack, President at PharmaLogic Development to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits
AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group
Barbara Wirostko to Speak at 5th Ocular Diseases Conference Mar 21-22, 2013
Barbara Wirostko, Chief Scientific Officer and Co-Founder of Jade Therapeutics and Clinical Adjunct Associate Professor of Ophthalmology at University of Utah to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Peter Adamson of GSK to Speak at 5th Ocular Diseases Conference Mar 21-22, 2013
Peter Adamson, Vice President and Head of Research and Ophthalmology at GlaxoSmithKline to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Samir Patel to Give Keynote at 5th Ocular Diseases Conference Mar 21-22, 2013
Samir Patel, President and CEO at Ophthotech to Give a Keynote Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Dr. Raymond Deshaies Speak at 3rd Ubiquitin Research and Drug Discovery Conference Feb 25-26, 2013 in Las Vegas, NV
3rd Ubiquitin Research and Drug Discovery Conference organized by GTCbio company. - January 10, 2013 - GTCbio
Dr. Aaron Ciechanover 2004 Nobel Prize Co-Winner Speak at Ubiquitin Research Conference (Organized by GTCbio company) Feb 25-26, 2013 in Las Vegas, NV
Dr. Aaron Ciechanover 2004 Nobel Prize Co-Winner and distinguished research professor in the Technion - Israel Institute of Technology in Haifa Will Give The Keynote Address “Intracellular Proteolysis and The Ubiquitin System: From The Backyard to The Center Stage of Biomedicne" at the 3rd Ubiquitin Research and Drug Discovery Conference organized by GTCbio company. - January 10, 2013 - GTCbio
ASI Launches Go-Path – Computerized Immunohistochemistry Cancer Analysis Aid
GenASIs Go-Path – Industry’s Most Advanced Computer Aided Membrane and Nuclear Immunohistochemistry Imaging and Analysis Platform - January 09, 2013 - Applied Spectral Imaging
ImmunoReagents Signs French Distributorship Agreement with Ozyme
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France. ImmunoReagents and Ozyme will partner to distribute top quality antibodies and... - January 04, 2013 - ImmunoReagents Inc.
ImmunoReagents Signs Swiss Distributorship Agreement with LabForce Ag
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of LabForce as its new distributor in Switzerland. ImmunoReagents and LabForce will partner to distribute top quality... - December 20, 2012 - ImmunoReagents Inc.
Applied Spectral Imaging Launches Version 7.2 of GenASIs – A New Era in Pathology and Cytogenetic Imaging
GenASIs 7.2 – The Market’s Most Comprehensive Computer Aided Cytogenetic and Pathology Imaging and Analysis Platform - December 20, 2012 - Applied Spectral Imaging
Charles W. Stiefel Appointed to M.D. Anderson Cancer Center Board of Visitors
Pharmaceutical Executive and Philanthropist Charles W. Stiefel has been appointed to the Board of Visitors of M.D. Anderson Cancer Center. - December 11, 2012 - Charles Stiefel Philanthropy
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012 - ALPCO
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012 - ALPCO
John F. Robyt, Ph.D. Recognized by Strathmore's Who's Who Worldwide Publication
John F. Robyt, Ph.D. of Ames, Iowa has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of education. About John F. Robyt, PH.D. Dr. Robyt has over 52 years experience in the field of education. He is a... - December 07, 2012 - Strathmore Worldwide
The Hamner Institutes for Health Sciences Announces Integrated Biology Initiative
Multi-Organization Partnership Will Promote Innovative Toxicity Testing Research - December 07, 2012 - The Hamner Institutes for Health Sciences